HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Johanning, K. Articles by Lindberg, I. Search for Related Content PubMed PubMed Citation Articles by Johanning, K. Articles by Lindberg, I. Social Bookmarking                      What's this?

Volume 271, Number 44, Issue of November 1, 1996 pp. 27871-27878
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Processing Site Blockade Results in More Efficient Conversion of Proenkephalin to Active Opioid Peptides

(Received for publication, April 17, 1996, and in revised form, July 8, 1996)

From the Department of Biochemistry and Molecular Biology, Louisiana State University School of Medicine, New Orleans, Louisiana 70112

Prohormones are known to be processed at various cleavage sites in a defined temporal order, suggesting the possibility of sequential unfolding of processing sites. In order to investigate whether sequential processing at predefined sites is in fact required for proper processing, site-directed mutagenesis was performed to block known initial cleavage sites within proenkephalin. Pulse-chase/immunoprecipitation experiments were employed to analyze the fate of mutant and native proenkephalins in stably transfected AtT-20 cells. While processing did not occur at blockaded sites, surprisingly, overall processing of mutant proenkephalins proceeded efficiently, and alternative sites were chosen. When compared with native proenkephalin, processing of mutant proenkephalins occurred more slowly at early stages and more quickly at later stages. Experiments employing endoglycosidase H indicated that the early slow processing of mutant proenkephalins may be due to delays in intracellular transport. Metabolic labeling studies showed that more efficient production of bioactive opioids occurred in all processing site blockade mutants examined; these results were confirmed using several different radioimmunoassays of stored peptide products. We conclude that efficient processing of prohormone precursors does not require a specific temporal order of processing events. The fact that mutant proenkephalins were more fully processed than native proenkephalin may provide a route for more efficient production of opioid peptides in applications for chronic pain treatment.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B. A. Barron Cardiac Opioids Experimental Biology and Medicine, May 1, 2000; 224(1): 1 - 7. [Abstract] [Full Text]

				B. A Barron Opioid peptides and the heart Cardiovasc Res, July 1, 1999; 43(1): 13 - 16. [Full Text] [PDF]

				K. Johanning, M. A. Juliano, L. Juliano, C. Lazure, N. S. Lamango, D. F. Steiner, and I. Lindberg Specificity of Prohormone Convertase 2 on Proenkephalin and Proenkephalin-related Substrates J. Biol. Chem., August 28, 1998; 273(35): 22672 - 22680. [Abstract] [Full Text] [PDF]

				X. Zhu, L. Muller, R. E. Mains, and I. Lindberg Structural Elements of PC2 Required for Interaction with Its Helper Protein 7B2 J. Biol. Chem., January 9, 1998; 273(2): 1158 - 1164. [Abstract] [Full Text] [PDF]